[1]
K. Shichiri, K. H. Tung, K. Takabe, and D. L. Bartlett, “Immune Checkpoint Inhibition for Hepatocellular Carcinoma, Cholangiocarcinoma, and Combined Hepatocellular-Cholangiocarcinoma”, World J Oncol, May 2025, doi: 10.14740/wjon2571.